Xiaofeng Yang Selected Research

Xiaofeng Yang Research Topics

Disease

91	Neoplasms (Cancer) 11/2022 - 01/2004
45	Inflammation (Inflammations) 01/2022 - 07/2012
22	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 02/2014
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2007
13	Infections 04/2022 - 03/2002
13	Atherosclerosis 01/2022 - 09/2006
12	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 08/2013
10	Asthma (Bronchial Asthma) 01/2021 - 09/2011
10	Hyperhomocysteinemia 01/2018 - 09/2006
9	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 05/2008
8	Epilepsy (Aura) 01/2022 - 01/2012
8	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2017
8	Metabolic Diseases (Metabolic Disease) 01/2021 - 11/2016
8	Acute Lung Injury 03/2018 - 01/2012
8	Xerostomia 02/2018 - 09/2012
7	Fibrosis (Cirrhosis) 01/2022 - 02/2013
7	Hyperlipidemias (Hyperlipidemia) 01/2021 - 11/2009
7	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2003
7	Respiratory Hypersensitivity 06/2016 - 01/2012
6	Non-Muscle Invasive Bladder Neoplasms 03/2022 - 07/2016
6	Wounds and Injuries (Trauma) 01/2022 - 05/2008
6	Chronic Renal Insufficiency 01/2022 - 11/2016
6	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 09/2012
5	Carcinogenesis 11/2022 - 05/2003
5	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 07/2017
5	COVID-19 01/2022 - 12/2020
5	Ischemia 10/2021 - 01/2017
5	Reperfusion Injury 10/2021 - 03/2015
5	Neoplasm Metastasis (Metastasis) 08/2021 - 07/2017
5	Nasopharyngeal Carcinoma 02/2018 - 11/2016
5	Hypoxia (Hypoxemia) 01/2018 - 08/2013
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022 - 07/2016
4	Seizures (Absence Seizure) 12/2020 - 01/2012
4	Thrombosis (Thrombus) 10/2020 - 01/2017
4	Carcinoma (Carcinomatosis) 01/2019 - 05/2014
3	Liver Neoplasms (Liver Cancer) 11/2022 - 12/2019
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2021
3	Necrosis 01/2022 - 01/2021
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2021 - 10/2019
3	Lymphoma (Lymphomas) 01/2021 - 08/2014

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
22	CytokinesIBA 01/2022 - 01/2012
18	EnzymesIBA 02/2022 - 01/2010
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2014
11	Pharmaceutical PreparationsIBA 04/2022 - 01/2007
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2016
10	InflammasomesIBA 01/2021 - 01/2016
9	Messenger RNA (mRNA)IBA 08/2021 - 01/2012
8	Apolipoproteins E (ApoE)IBA 01/2021 - 09/2006
7	oxidized low density lipoproteinIBA 01/2022 - 11/2016
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2002
7	Complement System Proteins (Complement)IBA 10/2021 - 08/2014
7	Protons (Proton)IBA 01/2021 - 01/2016
6	Caspase 1 (ICE Protease)IBA 01/2022 - 01/2016
6	LipidsIBA 01/2022 - 11/2016
6	AntibodiesIBA 10/2021 - 02/2006
6	InterleukinsIBA 01/2021 - 11/2013
6	LipopolysaccharidesIBA 01/2021 - 10/2012
6	Sirtuin 1IBA 08/2017 - 01/2015
5	Indicators and Reagents (Reagents)IBA 11/2022 - 05/2009
5	ChemokinesIBA 08/2021 - 01/2012
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2012
5	Mitogen-Activated Protein KinasesIBA 01/2021 - 09/2011
5	Therapeutic UsesIBA 03/2020 - 05/2008
5	ApolipoproteinsIBA 01/2018 - 09/2006
5	OvalbuminIBA 06/2015 - 01/2012
4	HomocysteineIBA 01/2022 - 01/2007
4	AntigensIBA 01/2022 - 02/2006
4	InterferonsIBA 01/2022 - 01/2021
4	CaspasesIBA 01/2022 - 10/2020
4	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
4	Immunoglobulin M (IgM)IBA 10/2021 - 03/2015
4	Phosphotransferases (Kinase)IBA 01/2021 - 07/2017
4	AntioxidantsIBA 01/2021 - 01/2016
4	Phosphates (Orthophosphate)IBA 01/2021 - 04/2012
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2017
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 11/2009
4	Immunoglobulin E (IgE)IBA 06/2016 - 01/2012
4	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2014 - 09/2006
4	Methacholine Chloride (Methacholine)FDA Link 12/2013 - 01/2012
3	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 10/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2020
3	Biological ProductsIBA 01/2022 - 02/2016
3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 05/2008
3	CholesterolIBA 05/2021 - 01/2020
3	NAD (NADH)IBA 01/2021 - 11/2015
3	Peptides (Polypeptides)IBA 01/2021 - 07/2016
3	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2019
3	ImmunosorbentsIBA 01/2021 - 04/2012
3	VaccinesIBA 01/2021 - 02/2009
3	ChromatinIBA 01/2021 - 11/2016

Therapy/Procedure

47	Radiotherapy 11/2022 - 09/2012
35	Therapeutics 03/2022 - 04/2006
10	Transplantation 01/2022 - 09/2008
6	Brachytherapy 11/2021 - 01/2014
4	Transurethral Resection of Bladder 03/2022 - 04/2020
4	Drug Therapy (Chemotherapy) 01/2021 - 10/2018
3	Decompressive Craniectomy 04/2022 - 08/2005